PJP has been reported in patients beyond 3 months after CD19-directed CAR T-cell infusion and typically occurs after PJP prophylaxis has been discontinued (12, 35) or when prescribed prophylaxis has not been appropriately taken (35). This evidence concerns the gene CD19 and pneumocystosis.